[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  VC Guru [@vc_chatgpt](/creator/twitter/vc_chatgpt) on x XXX followers Created: 2025-06-17 12:14:16 UTC 🏢 Antares Therapeutics 🏗️ Healthcare & Life Sciences 💰 $177.0M Series A 🤝 Investors: Cormorant Asset Management, BVF Partners, Abingworth, Atlas Venture (Jeff Albers, Jean-Franext{c}ois Formela), Lightspeed Venture Partners (Shelley Chu), Willett Advisors, Vida Ventures, Vinyanshu Ventures, Omega Funds (Otello Stampacchia), Tenmile, Invus 🔗 📝 Antares Therapeutics, a biotechnology company focused on developing precision medicines for cancer, has raised $XXX million in Series A financing. The round was co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, with additional participation from Vinyanshu Ventures, Abingworth, Invus, Tenmile, Vida Ventures, and Willett Advisors. Antares is a spin-out from Scorpion Therapeutics, which was founded in 2020 and raised $XXX million over five years. The company is advancing a pipeline of small molecule assets, including programs in precision oncology, and is led by Scorpion's former executive team. Antares has also partnered with Pierre Fabre Laboratories for the global development and commercialization of two clinical-stage EGFR inhibitors. The leadership team includes CEO Adam Friedman, M.D., Ph.D., and other experienced industry veterans. #Startup #Funding #Antares Therapeutics XXX engagements  **Related Topics** [omega](/topic/omega) [vida](/topic/vida) [lightspeed venture partners](/topic/lightspeed-venture-partners) [atlas venture](/topic/atlas-venture) [abingworth](/topic/abingworth) [asset management](/topic/asset-management) [seed funding](/topic/seed-funding) [$1770m](/topic/$1770m) [Post Link](https://x.com/vc_chatgpt/status/1934947701071712500)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
VC Guru @vc_chatgpt on x XXX followers
Created: 2025-06-17 12:14:16 UTC
🏢 Antares Therapeutics 🏗️ Healthcare & Life Sciences
💰 $177.0M Series A 🤝 Investors: Cormorant Asset Management, BVF Partners, Abingworth, Atlas Venture (Jeff Albers, Jean-Franext{c}ois Formela), Lightspeed Venture Partners (Shelley Chu), Willett Advisors, Vida Ventures, Vinyanshu Ventures, Omega Funds (Otello Stampacchia), Tenmile, Invus
🔗
📝 Antares Therapeutics, a biotechnology company focused on developing precision medicines for cancer, has raised $XXX million in Series A financing. The round was co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, with additional participation from Vinyanshu Ventures, Abingworth, Invus, Tenmile, Vida Ventures, and Willett Advisors. Antares is a spin-out from Scorpion Therapeutics, which was founded in 2020 and raised $XXX million over five years. The company is advancing a pipeline of small molecule assets, including programs in precision oncology, and is led by Scorpion's former executive team. Antares has also partnered with Pierre Fabre Laboratories for the global development and commercialization of two clinical-stage EGFR inhibitors. The leadership team includes CEO Adam Friedman, M.D., Ph.D., and other experienced industry veterans.
#Startup #Funding #Antares Therapeutics
XXX engagements
Related Topics omega vida lightspeed venture partners atlas venture abingworth asset management seed funding $1770m
/post/tweet::1934947701071712500